Antisense estrogen receptor RNA expression increases epidermal growth factor receptor gene expression in breast cancer cells

Cell Growth and Differentiation

Volumn 8, Issue 8, 1997, Pages 903-911

  DeFazio, Anna ^a,b   Chiew, Yoke Eng ^a,b   McEvoy, Maryanne ^a   Watts, Colin K W ^a   Sutherland, Robert L ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; MESSENGER RNA;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; RECEPTOR DENSITY; TUMOR GROWTH;

BREAST NEOPLASMS; ESTRADIOL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; RECEPTORS, GLUCOCORTICOID; RNA, ANTISENSE; RNA, MESSENGER; RNA, NEOPLASM; TRANSFECTION; TUMOR CELLS, CULTURED; ZINC;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0030795062     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. McGuire, W. L. Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin. Oncol., 5: 428-432, 1978.
2. McGuire, W., and Clark, G. Prognostic factors and treatment decisions in axillary node-negative breast cancer. N. Engl. J. Med., 326: 1756-1761, 1992.
3. Van Agthoven, T., Van Agthoven, T. L. A., Portengen, H., Foekens, J. A., and Dorssers, L. C. J. Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells. Cancer Res., 52: 5082-5088, 1992.
4. Harris, A. L., Nicholson, S., Sainsbury, J. R., Farndon, J., and Wright, C. Epidermal growth factor receptors in breast cancer: association with early relapse and death, poor response to hormones, and interactions with neu. J. Steroid Biochem., 34: 123-131, 1989.
5. Nicholson, S., Wright, C., Sainsbury, J. R., Halcrow, P., Kelly, P., Angus, B., Farndon, J. R., and Harris, A. L. Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: neu and tamoxifen failure. J. Steroid Biochem. Mol. Biol., 37: 811-814, 1990.
6. Sainsbury, J. R. C., Farndon, J. R., Needham, G. K., Malcolm, A. J., and Harris, A. L. Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet, i: 1398-1402, 1987.
7. Klijn, J. G. M., Berns, P. M. J. J., Schmitz, P. I. M., and Foekens, J. A. The clinical significance of epidermal growth factor receptor (EGFR) in human breast cancer: a review on 5232 patients. Endocr. Rev., 13: 3-17, 1992.
8. Sainsbury, J. R. C., Farndon, J. R., Sherbet, G. V., and Harris, A. L. Epidermal growth factor receptors and oestrogen receptors in human breast cancer. Lancet, i: 364-366, 1985.
9. Pérez, R., Pascual, M., Macias, A., and Lage, A. Epidermal growth factor receptors in human breast cancer. Breast Cancer Res. Treat., 4: 189-193, 1984.
10. Davidson, N. E., Gelmann, E. P., Lippman, M. E., and Dickson, R. B. Epidermal growth factor receptor gene expression in estrogen receptor-positive and -negative human breast cancer cell lines. Mol. Endocrinol., 1: 216-223, 1987.
11. Hall, R. E., Lee, C. S. L., Alexander, I. E., Shine, J., Clarke, C. L., and Sutherland, R. L. Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels. Int. J. Cancer, 46: 1081-1087, 1990.
12. Lee, C. S. L., Hall, R. E., Alexander, I. E., Koga, M., Shine, J., and Sutherland, R. L. Inverse relationship between estrogen receptor and epidermal growth factor receptor mRNA levels in human breast cancer cell lines. Growth Factors, 3: 97-103, 1990.
13. Koenders, P. G., Beex, L. V. A. M., Geurts-Moespot, A., Heuvel, J. J. T. M., Kienhuis, C. B. M., and Benraad, T. J. Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers. Cancer Res., 51: 4544-4548, 1991.
14. Sharma, A. K., Horgan, K., Douglas-Jones, A., McClelland, R., Gee, J., and Nicholson, R. Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer. Br. J. Cancer, 69: 1032-1037, 1994.
15. Lee, C. S. L., Koga, M., and Sutherland, R. L. Modulation of estrogen receptor and epidermal growth factor receptor mRNAs by phorbol ester in MCF-7 breast cancer cells. Biochem. Biophys. Res. Commun., 162: 415-421, 1989.
16. Saceda, M., Knabbe, C., Dickson, R. B., Lippman, M. E., Bronzert, D., Lindsey, R. K., Gottardis, M. M., and Martin, M. B. Post-transcriptional destabilization of estrogen receptor messenger RNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13-acetate. J. Biol. Chem., 266: 17809-17814, 1991.
17. deFazio, A., Chiew, Y. E., Donoghue, C., Lee, C. S. L., and Sutherland, R. L. Effect of sodium butyrate on estrogen receptor and epidermal growth factor receptor gene expression in human breast cancer cell lines. J. Biol. Chem., 267: 18008-18012, 1992.
18. Lee, C. S. L., deFazio, A., Ormandy, C. J., and Sutherland, R. L. Inverse regulation of oestrogen receptor and epidermal growth factor receptor gene expression in MCF-7 breast cancer cells treated with phorbol ester. J. Steroid Biochem. Mol. Biol., 58: 267-275, 1996.
19. Valverius, E. M., Velu, T., Shankar, V., Ciardiello, F., Kim, N., and Salomon, D. S. Over-expression of the epidermal growth factor receptor in human breast cancer cells fails to induce an estrogen-independent phenotype. Int. J. Cancer, 46: 712-718, 1990.
20. Watts, C. K. W., and King, R. J. B. Overexpression of estrogen receptor in HTB 96 human osteosarcoma cells results in estrogen-induced growth inhibition and receptor cross-talk. J. Bone. Miner. Res., 9: 1251-1258, 1994.
21. Jiang, S. Y., and Jordan, V. C. Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J. Natl. Cancer Inst., 84: 580-591, 1992.
22. Zajchowski, D. A., Sager, R., and Webster, L. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Res., 53: 5004-5011, 1993.
23. Izant, J. G., and Weintraub, H. Constitutive and conditional suppression of exogenous and endogenous genes by antisense RNA. Science (Washington DC), 229: 345-352, 1985.
24. Murphy, P., and Knee, R. Identification and characterization of an antisense RNA transcript (gfg) from the human basic fibroblast growth factor gene. Mol. Endocrinol., 8: 852-859, 1994.
25. Clemmons, D. R., Camacho-Hubner, C., Coronado, E., and Osborne, C. K. Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status. Endocrinology, 127: 2679-2686, 1990.
26. Armstrong, D. K., Isaacs, J. T., Ottaviano, Y. L., and Davidson, N. E. Programmed cell death in an estrogen-independent human breast cancer cell line, MDA-MB-468. Cancer Res., 52: 3418-3424, 1992.
27. Castles, C. G., Fuqua, S. A., Klotz, D. M., and Hill, S. M. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line. Cancer Res., 53: 5934-5939, 1993.
28. Lasfargues, E. Y., Coutinho, W. G., and Redfield, E. S. Isolation of two human tumor epithelial cell lines from solid breast carcinomas. J. Natl. Cancer Inst., 61: 967-978, 1978.
29. Horwitz, K. B., Zava, D. T., Thilagar, A. K., Jensen, E. M., and McGuire, W. L. Steroid receptor analyses of nine human breast cancer cell lines. Cancer Res., 38: 2434-2437, 1978.
30. Lebeau, J., and Goubin, G. Amplification of the epidermal growth factor receptor gene in the BT20 breast carcinoma cell line. Int. J. Cancer, 40: 189-191, 1987.
31. Kraus, M. H., Popescu, N. C., Amsbaugh, S. C., and King, C. R. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J., 6: 605-610, 1987.
32. Filmus, J., Pollak, M. N., Cailleau, R., and Buick, R. N. MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth-inhibited by EGF. Biochem. Biophys. Res. Commun., 128: 898-905, 1985.
33. Allegra, J. C., Lippman, M. E., Thompson, E. B., Simon, R., Barlock, A., Green, L., Huff, K. K., Do, H. M., and Aitken, S. C. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Cancer Res., 39: 1447-1454, 1979.
34. Xu, J., Thompson, K. L., Shephard, L. B., Hudson, L. G., and Gill, G. N. T3 receptor suppression of Sp1-dependent transcription from the epidermal growth factor receptor promoter via overlapping DNA-binding sites. J. Biol. Chem., 268: 16065-16073, 1993.
35. Kageyama, R., and Pastan, I. Molecular cloning and characterization of a human DNA binding factor that represses transcription. Cell, 59: 815-825, 1989.
36. Van Dijck, P., and Verhoeven, G. Interaction of estrogen receptor complexes with the promoter region of genes that are negatively regulated by estrogens: the α2u-globulins. Biochem. Biophys. Res. Commun., 182: 174-181, 1992.
37. Schroeder, C., Gibson, L., Nordstrom, C., and Beug, H. The estrogen receptor cooperates with the TGF-α receptor (c-erbB) in regulation of chicken erythroid progenitor self-renewal. EMBO J., 12: 951-960, 1993.
38. Murphy, L. J., Sutherland, R. L., Stead, B., Murphy, L. C., and Lazarus, L. Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells. Cancer Res., 46: 728-734, 1986.
39. Yarden, R. I., Lauber, A. H., El-Ashry, D., and Chrysogelos, S. A. Bimodal regulation of epidermal growth factor receptor by estrogen receptor in breast cancer cells. Endocrinology, 137: 2739-2747, 1996.
40. Read, L. D., Greene, G. L., and Katzenellenbogen, B. S. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Mol. Endocrinol., 3: 295-304, 1989.
41. Saceda, M., Lippman, M. E., Lindsey, R. K., Puente, M., and Martin, M. B. Role of an estrogen receptor-dependent mechanism in the regulation of estrogen receptor mRNA in MCF-7 cells. Mol. Endocrinol., 3: 1782-1787, 1989.
42. Hörlein, A. J., Naar, A. M., Heinzel, T., Torchia, J., Gloss, B., Kurokawa, R., Ryan, A., Kamei, Y., Soderstrom, M., Glass, C. K., and Rosenfeld, M. G. Ligand-independent repression of the thyroid hormone receptor mediated by a nuclear co-repressor. Nature (Lond.), 377: 397-404, 1995.
43. Chen, J. D., and Evans, R. M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature (Lond.), 377: 454-457, 1995.
44. Haley, J. D., and Waterfield, M. D. Contributory effects of de novo transcription and premature transcript termination in the regulation of human epidermal growth factor receptor proto-oncogene RNA synthesis. J. Biol. Chem., 266: 1746-1753, 1991.
45. Chrysogelos, S. A., Yarden, R. I., Lauber, A. H., and Murphy, J. M. Mechanisms of EGF receptor regulation in breast cancer cells. Breast Cancer Res. Treat., 31: 227-236, 1994.
46. Riegel, A. T., Aitken, S. C., Martin, M. B., and Schoenberg, D. R. Posttranscriptional regulation of albumin gene expression in Xenopus liver: evidence for an estrogen receptor-dependent mechanism. Mol. Endocrinol., 1: 160-167, 1987.
47. Celano, P., Berchtold, C. M., Kizer, D. L., Weeraratna, A., Nelkin, B. D., Baylin, S. B., and Casero, R. A. Characterization of an endogenous RNA transcript with homology to the antisense strand of the human c-myc gene. J. Biol. Chem., 267: 15092-15096, 1992.
48. Koenders, P. G., Beex, L. V. A. M., Kienhuis, C. B. M., Kloppenborg, P. W. C., and Benraad, T. J. Epidermal growth factor receptor and prognosis in human breast cancer: a prospective study. Breast Cancer Res. Treat., 25: 21-27, 1993.
49. Long, B., McKibben, B. M., Lynch, M., and van den Berg, H. W. Changes in epidermal growth factor receptor expression and response to ligand associated with acquired tamoxifen resistance or oestrogen independence in the ZR-75-1 human breast cancer cell line. Br. J. Cancer, 65: 865-869, 1992.
50. Newton, C. J., Buric, R., Trapp, T., Brockmeier, S., Pagotto, U., and Stalla, G. K. The unliganded estrogen receptor (ER) transduces growth factor signals. J. Steroid Biochem. Mol. Biol., 48: 481-486, 1994.
51. Ignar-Trowbridge, D. M., Nelson, K. G., Bidwell, M. C., Curtis, S. W., Washburn, T. F., McLachlan, J. A., and Korach, K. S. Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc. Natl. Acad. Sci. USA, 89: 4658-4662, 1992.
52. Reddel, R. R., Murphy, L. C., Hall, R. E., and Sutherland, R. L. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen. Cancer Res., 45: 1525-1531, 1985.
53. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
54. Walter, P., Green, S., Greene, G., Krust, A., Bornert, J-M., Jeltsch, J-M., Staub, A., Jensen, E., Scrace, G., Waterfield, M., and Chambon, P. Cloning of the human estrogen receptor cDNA. Proc. Natl. Acad. Sci. USA, 82: 7889-7893, 1985.
55. Libermann, T. A., Nusbaum, H. R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M. D., Ullrich, A., and Schlessinger, J. Amplification, enhanced expression, and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature (Lond.), 313: 144-147, 1985.
56. Malden, L. T., Novak, U., Kaye, A. H., and Burgess, A. W. Selective amplification of the cytoplasmic domain of the epidermal growth factor receptor gene in glioblastoma multiforme. Cancer Res., 48: 2711-2714, 1988.
57. Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Thompson, E. B., Rosenfeld, M. G., and Evans, R. M. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature (Lond.), 318: 635-641, 1985.
58. Chan, Y-L., Gutell, R., Noller, H. F., and Wool, I. G. The nucleotide sequence of a rat 18 S ribosomal ribonucleic acid gene and a proposal for the secondary structure of 18 S ribosomal ribonucleic acid. J. Biol. Chem., 259: 224-230, 1984.
59. Morley, A., Trainor, K., and Seshadri, R. Cloning of human lymphocytes using limiting dilution. Exp. Hematol. (NY), 11: 426-432, 1983.
60. Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J. M., Argos, P., and Chambon, P. Human oestrogen receptor cDNA: sequence, expression, and homology to v-erb-A. Nature (Lond.), 320: 134-139, 1986.
61. Greene, G. L., Gilna, P., Waterfield, M., Baker, A., Hort, Y., and Shine, J. Sequence and expression of human estrogen receptor complementary DNA. Science (Washington DC), 231: 1150-1154, 1986.
62. Tora, L., Mullick, A., Metzger, D., Ponglikitmongkol, M., Park, I., and Chambon, P. The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J., 8: 1981-1986, 1989.
63. Kushner, P. J., Hort, E., Shine, J., Baxter, J. D., and Greene, G. L. Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens. Mol. Endocrinol., 4: 1465-1473, 1990.
64. Sutherland, R. L., Hall, R. E., Pang, G. Y., Musgrove, E. A., and Clarke, C. L. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells. Cancer Res., 48: 5084-5091, 1988.